Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMIGOS: Ovarian Stimulation for Unexplained Infertility
NCT01044862Phase 3Completed
- Sponsor
- Yale University
- Start
- Jun 2010
- Primary completion
- Oct 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of letrozole in Unexplained infertility (3 arms), sponsored by Yale University. Primary endpoint: Multiple Gestation Rate Following Recruitment of Multiple Follicular Development With an AI, as Compared to CC and FSH up to 66 weeks. Started Jun 2010; status: completed.
02
Drugs
letrozole
03
Conditions
Unexplained infertility
Beyond the preview
Go deeper on NCT01044862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01044862.